| Description | RS5517 is a novel PDZ1 structural domain ligand for the study of colorectal cancer. |
| Synonyms | RS-5517, RS 5517 |
| molecular weight | 390.86 |
| Molecular formula | C23H19ClN2O2 |
| CAS | 2227017-46-9 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| References | 1. Saponaro C, et al. β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy. Oncogene. 2018 Jun;37(24):3301-3316. 2. Capdevielle C, et al. HDAC inhibition induces expression of scaffolding proteins critical for tumor progression in pediatric glioma: focus on EBP50 and IRSp53. Neuro Oncol. 2020 Apr 15;22(4):550-562. |